Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Verlinde

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Neuropeptides|December 1, 1984
The kappa-active oxygen in the opioid pharmacophore of some benzomorphans: charges, proton affinities and binding modellingC J De Ranter, C L Verlinde, N M Blaton, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|December 15, 1989
Structure and absolute configuration of two stereoisomers of alpha,alpha'-[iminobis-(methylene)]bis(3,4-dihydro-2H-1-benzopyran-2- methanol) hydrobromideO M Peeters, C L Verlinde, N M Blaton, et al.
The Journal of Biological Chemistry|November 24, 1999
Using a galactose library for exploration of a novel hydrophobic pocket in the receptor binding site of the Escherichia coli heat-labile enterotoxinW E Minke, F Hong, C L Verlinde, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 15, 1989
Structure and conformational analysis of the opioid antagonist (-)-(1R,5R,9R)-5,9-diethyl-2-(3-furylmethyl)-2'-hydroxy-6,7-benzomorpha n (Mr2266)C L Verlinde, N M Blaton, O M Peeters, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|May 15, 1989
Structure of a kappa-opioid receptor misfit: (1S,5R,8R,9R)-2'-hydroxy-5,9-dimethyl-8,2-epoxyethano-6,7-benzomorphan hydrochlorideC L Verlinde, N M Blaton, C J De Ranter, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidaseF S Buckner, C L Verlinde, A C La Flamme, et al.
Biochemistry|November 21, 1995
Crystal structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Leishmania mexicana: implications for structure-based drug design and a new position for the inorganic phosphate binding siteH Kim, I K Feil, C L Verlinde, et al.
Acta Crystallographica. Section D, Biological Crystallography|August 10, 2000
Structure of m-carboxyphenyl-alpha-D-galactopyranoside complexed to heat-labile enterotoxin at 1.3 A resolution: surprising variations in ligand-binding modesW E Minke, J Pickens, E A Merritt, et al.
Structure (London, England : 1993)|January 15, 1995
Three-dimensional structure of the diphtheria toxin repressor in complex with divalent cation co-repressorsX Qiu, C L Verlinde, S Zhang, et al.
European Journal of Biochemistry|May 23, 1991
Anion binding at the active site of trypanosomal triosephosphate isomerase. Monohydrogen phosphate does not mimic sulphateC L Verlinde, M E Noble, K H Kalk, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Neuropeptides|December 1, 1984
The kappa-active oxygen in the opioid pharmacophore of some benzomorphans: charges, proton affinities and binding modellingC J De Ranter, C L Verlinde, N M Blaton, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|December 15, 1989
Structure and absolute configuration of two stereoisomers of alpha,alpha'-[iminobis-(methylene)]bis(3,4-dihydro-2H-1-benzopyran-2- methanol) hydrobromideO M Peeters, C L Verlinde, N M Blaton, et al.
The Journal of Biological Chemistry|November 24, 1999
Using a galactose library for exploration of a novel hydrophobic pocket in the receptor binding site of the Escherichia coli heat-labile enterotoxinW E Minke, F Hong, C L Verlinde, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 15, 1989
Structure and conformational analysis of the opioid antagonist (-)-(1R,5R,9R)-5,9-diethyl-2-(3-furylmethyl)-2'-hydroxy-6,7-benzomorpha n (Mr2266)C L Verlinde, N M Blaton, O M Peeters, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|May 15, 1989
Structure of a kappa-opioid receptor misfit: (1S,5R,8R,9R)-2'-hydroxy-5,9-dimethyl-8,2-epoxyethano-6,7-benzomorphan hydrochlorideC L Verlinde, N M Blaton, C J De Ranter, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidaseF S Buckner, C L Verlinde, A C La Flamme, et al.
Biochemistry|November 21, 1995
Crystal structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Leishmania mexicana: implications for structure-based drug design and a new position for the inorganic phosphate binding siteH Kim, I K Feil, C L Verlinde, et al.
Acta Crystallographica. Section D, Biological Crystallography|August 10, 2000
Structure of m-carboxyphenyl-alpha-D-galactopyranoside complexed to heat-labile enterotoxin at 1.3 A resolution: surprising variations in ligand-binding modesW E Minke, J Pickens, E A Merritt, et al.
Structure (London, England : 1993)|January 15, 1995
Three-dimensional structure of the diphtheria toxin repressor in complex with divalent cation co-repressorsX Qiu, C L Verlinde, S Zhang, et al.
European Journal of Biochemistry|May 23, 1991
Anion binding at the active site of trypanosomal triosephosphate isomerase. Monohydrogen phosphate does not mimic sulphateC L Verlinde, M E Noble, K H Kalk, et al.
Pageof 4